Increased variability [GxP / QC / QA]

posted by Ohlbe – France, 2021-09-17 19:56 (507 d 11:00 ago) – Posting: # 22585
Views: 3,807

Hi Helmut,

❝ The CVs calculated from the confidence intervals in both ‘parts’ are much lower than the ones in the ‘full’ study. Or the other way ’round: If we pool the CVs of the ‘parts’ we could expect values which are lower than the ‘observed’ (tee-hee!) ones.


Yep. The effect on the MSE is clearly visible on Figure 4 of the paper linked by ElMaestro.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
23 visitors (0 registered, 23 guests [including 14 identified bots]).
Forum time: 05:56 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5